11-59364475-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_001004729.2(OR5AN1):āc.17A>Gā(p.Asn6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,457,464 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004729.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5AN1 | NM_001004729.2 | c.17A>G | p.Asn6Ser | missense_variant | 2/2 | ENST00000641998.1 | NP_001004729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5AN1 | ENST00000641998.1 | c.17A>G | p.Asn6Ser | missense_variant | 2/2 | NM_001004729.2 | ENSP00000493250.1 | |||
OR5AN1 | ENST00000313940.2 | c.17A>G | p.Asn6Ser | missense_variant | 1/1 | 6 | ENSP00000320302.2 | |||
OR5AN1 | ENST00000641850.1 | c.17A>G | p.Asn6Ser | missense_variant | 2/2 | ENSP00000492957.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246834Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133214
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1457464Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 724720
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.17A>G (p.N6S) alteration is located in exon 1 (coding exon 1) of the OR5AN1 gene. This alteration results from a A to G substitution at nucleotide position 17, causing the asparagine (N) at amino acid position 6 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at